[ARCHIVE]2026-08-12T12:03:04.496457+00:00
Canaccord lowers Neurogene stock price target on valuation review By Investing.com
Executive Summary
Canaccord lowers Neurogene stock price target on valuation review
Deep analysis unavailable for this source.
View Original SourceClassification: Open